High Court Rebuffs Bayer Bid To Revive Yasmin Patent
The U.S. Supreme Court has refused to hear an appeal from Bayer Schering Pharma AG, ending the pharmaceutical company's bid to overturn lower court rulings invalidating its patent for oral contraceptive...To view the full article, register now.
Already a subscriber? Click here to view full article